Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Cells · 2023
DOI: 10.3390/cells12212518 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Mauro Maniscalco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Ricerca Corrente” funding scheme of the Ministry of Health, Italy.
Abstract (Originalsprache)
Nitric oxide (NO) is a short-lived gas molecule which has been studied for its role as a signaling molecule in the vasculature and later, in a broader view, as a cellular messenger in many other biological processes such as immunity and inflammation, cell survival, apoptosis, and aging. Fractional exhaled nitric oxide (FeNO) is a convenient, easy-to-obtain, and non-invasive method for assessing active, mainly Th2-driven, airway inflammation, which is sensitive to treatment with standard anti-inflammatory therapy. Consequently, FeNO serves as a valued tool to aid the diagnosis and monitoring of several asthma phenotypes. More recently, FeNO has been evaluated in several other respiratory and/or immunological conditions, including allergic rhinitis, chronic rhinosinusitis with/without nasal polyps, atopic dermatitis, eosinophilic esophagitis, and food allergy. In this review, we aim to provide an extensive overview of the current state of knowledge about FeNO as a biomarker in type 2 inflammation, outlining past and recent data on the application of its measurement in patients affected by a broad variety of atopic/allergic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, Italy.
- Department of Translational Medical Sciences, Federico II University, 80131 Naples, Italy.
- Department of Neuroscience, Reproductive and Odontostomatological Sciences-ENT Section, University of Naples Federico II, 80131 Naples, Italy.
ORCID-Profile: Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, Elena Cantone
Förderung
- “Ricerca Corrente” funding scheme of the Ministry of Health, Italy
Zitieren
APA
Maniscalco, M., Fuschillo, S., Mormile, I., Detoraki, A., Sarnelli, G., Paulis, A., Spadaro, G., Cantone, E., & PATH-2 TASK FORCE (2023). Exhaled Nitric Oxide as Biomarker of Type 2 Diseases. Cells. https://doi.org/10.3390/cells12212518
Vancouver
Maniscalco M, Fuschillo S, Mormile I, Detoraki A, Sarnelli G, Paulis A, et al. Exhaled Nitric Oxide as Biomarker of Type 2 Diseases. Cells. 2023. doi:10.3390/cells12212518
BibTeX
@article{Maniscalco2023,
author = {Maniscalco, Mauro and Fuschillo, Salvatore and Mormile, Ilaria and Detoraki, Aikaterini and Sarnelli, Giovanni and Paulis, Amato de and Spadaro, Giuseppe and Cantone, Elena and PATH-2 TASK FORCE, PATH-2 TASK FORCE},
title = {Exhaled Nitric Oxide as Biomarker of Type 2 Diseases},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12212518}
}
EUVIMED